Experts predict growth in Pharma-AI use research
The End of Silicon Valley as We Know It?
How AI Is Aiming at the Bad Math of Drug Development
Alpha Connector - Robert Marcus - Founder, and CEO of Alpha10X
Venture Investors Turn To AI To Find Deal
Cambridge-1 and the future of medicine
Drug discovery platform Exscientia sets terms for $275 million US IPO
Experts discuss barriers to deep tech ventures
Analyst reports trend in LS research funding
Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X
ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding
3 Myths About Women Working in Tech, Busted
